AWAKN™ Life Sciences capitalises on evidence based Psychedelic Assisted Psychotherapy solutions to heal the mental state of the UK.
Awakn's focus is ensuring optimal patient safety, while delivering efficacy through transformative patient care, in conjunction with scientifically validating long-term mental health.
On-demand research and clinical trials – study design, enrollment, execution – for the medicalisation of psychedelic assisted therapy. Advancing mental health through pre-clinical, Phase I-III, regulatory submissions and IP creation.
A revolutionary shift in the treatment approach for mental health disorders, under the leadership of psychiatric specialist, researcher, author and clinic founder, Dr. Ben Sessa.
Scalable clinical training & knowledge management platform for Psychiatrists and Psychologists to understand the protocols and power of psychedelics as an aide to therapy. Includes modules for: live group events; training simulators and online video learning.